Skip to main content
. 1997 Jun 16;137(6):1287–1307. doi: 10.1083/jcb.137.6.1287

Table I.

Antibodies Used in This Study

Antibody Source Raised against Purified against Reference
rafMIβ rabbit serum frog myosin-Iβ, aa 760–1,028/MBP This study
 aa 899–1,028/His6
20-3-2 mouse IgM monoclonal bovine myosin-Iβ M.C. Wagner, unpublished data
32A rabbit serum chicken myosin-V, aa 899–1,830/His6 Espreafico et al., 1992
 aa 899–1,830/MBP
rapMVI rabbit serum pig myosin-VI, aa 1,049–1,254/His6 Hasson and Mooseker, 1994
 aa 1,049–1,254/GST
mapMVI mouse serum pig myosin-VI, aa 1,049–1,254/His6 This study
 aa 1,049–1,254/GST
rapMVI rabbit serum frog myosin-VI, This study
 aa 291–305
rahMVIIa rabbit serum human myosin-VIIa, aa 877–1,075/His6 Hasson et al., 1995
 aa 877–1,075/GST
mahMVIIa mouse serum human myosin-VIIa, aa 877–1,075/His6 This study
aa 877–1,075/GST

aa, start and finish amino acids of recombinant fragments from relevant myosin isozyme; His6, hexahistidine fusion using pQE vectors; MBP, maltose-binding protein fusion using pMAL-p; GST, glutathione-S-transferase fusion using pGEX vectors.